Adaptable: The Aspirin Study
10 March, 2016

Adaptable: The Aspirin Study

PCORnet study comparing aspirin maintenance dosage for the prevention of repeat coronary events in tandem with evaluating adverse gastrointestinal events. This trial will take place in cardiology clinics through use of the PTAS.

PCORnet study comparing aspirin maintenance dosage for the prevention of repeat coronary events in tandem with evaluating adverse gastrointestinal events. This trial will take place in cardiology clinics through use of the PTAS.

Learn More
The Natural Experiments Network (NEN)
9 March, 2016

The Natural Experiments Network (NEN)

NEN is a study REACHnet is involved in that was funded in 2016, and has a project period that lasts for the next five years. This study focuses on collaboration in diabetes management through non-face-to-face care coordination to enhance outcomes. This is a patient focused study and has constant engagement with patients and

NEN is a study REACHnet is involved in that was funded in 2016, and has a project period that lasts for the next five years. This study focuses on collaboration in diabetes management through non-face-to-face care coordination to enhance outcomes. This is a patient focused study and has constant engagement with patients and stakeholders in every step of the process. REACHnet is leveraging our Diabetes Advisory Group (DAG) to maximize the effectiveness of this research.

Learn More